SCHEMBL26961895

SCHEMBL26961895

CC(C)(C)OC(=O)N[C@H]1CS(=O)(=O)c2cc(F)c(-c3noc(C4(C)CCN(C(=O)OCc5ccccc5)CC4)n3)cc2N(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.35
▸ TRPC3 Q13507 1/20 0.33
▸ TRPC7 Q9HCX4 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPY1R P25929 1/20 0.33
▸ BDKRB1 P46663 3/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.31
▸ RORC P51449 2/20 0.31
▸ SMO Q99835 1/20 0.31
▸ OPRD1 P41143 2/20 0.31
▸ OPRK1 P41145 2/20 0.31
▸ XIAP P98170 1/20 0.31
▸ BIRC2 Q13490 1/20 0.31
▸ PARP1 P09874 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26961935 0.93 BDKRB1 (0.34) THRBMAPTBDKRB1S1PR1SMO
SCHEMBL26961838 0.90 BDKRB1 (0.34) THRBBDKRB1S1PR1SMO
SCHEMBL26961839 0.89 BDKRB1 (0.35) THRBNPY1RBDKRB1S1PR1
SCHEMBL26962129 0.88 TRPC3 (0.34) THRBTRPC3TRPC7MAPTNPY1R
SCHEMBL26961648 0.88 BDKRB1 (0.35) BDKRB1S1PR1HDAC1HDAC8HDAC6
SCHEMBL26961633 0.87 BDKRB1 (0.35) MAPTNPY1RBDKRB1S1PR1HDAC1
SCHEMBL26962059 0.85 S1PR1 (0.32) THRBNPY1RS1PR1RORCPARP1
SCHEMBL26962021 0.84 BDKRB1 (0.36) MAPTNPY1RBDKRB1S1PR1XIAP
SCHEMBL26961786 0.84 BDKRB1 (0.33) BDKRB1
SCHEMBL26961800 0.81 HDAC6 (0.38) MAPTNPY1RBDKRB1S1PR1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback